Eamon Hughey

Orders Problem: Back pain Past: Chest wall deformity (pectus) Social: Student, starting high school next week Habits: Screen use at night Med: Sertraline, every morning Data: Oura ring has been used for a few months for heart rate and sleep

Narrative: SPRUCE MESSAGE VISIT Date: 2026-08-14 Encounter: Spruce text message CC: Parent requests guanfacine refill at reduced summer dose of 1.5mg due to difficulty splitting 3mg tablets cleanly. HPI: Eamon has been taking a reduced dose

Narrative: want's to d/c guanfacine over the summer to trial off dx asd by rachelle hansen doing therapy with her unclear on how much guanfacine helped or not - still see change in energy level on it (decreased) unsure how much sertraline i

Narrative: SPRUCE MESSAGE VISIT Date: 2026-05-11 Encounter: Spruce text message (phone call/check-in scheduled but not yet completed within conversation date range) CC: Parent requests medication management review for summer (possible reduc

Narrative: SPRUCE MESSAGE VISIT Date: 2026-03-02 CC: Continued sleep-onset insomnia with restlessness HPI: Eamon went to bed at 10pm but did not fall asleep until approximately 11:40pm, representing nearly two hours of sleep-onset latency.

Narrative: SPRUCE MESSAGE VISIT Date: 2026-03-01 CC: Ongoing fatigue and poor sleep quality; request for further workup HPI: Eamon continues to experience significant fatigue that parents describe as abnormal. Despite previously reporting s

Narrative: SPRUCE MESSAGE VISIT Date: 2026-02-28 Encounter: Spruce text message CC: Excessive fatigue, insomnia, and bradycardia possibly related to guanfacine; request to decrease or discontinue medication. HPI: Parents reported that over

Narrative: # Consultation on Eamon's Behavioral and Emotional Challenges [image] ## The Presenting Crisis and Underlying Emotional State Eamon was suspended today for a single day following an incident in the school lunchroom where he used

Narrative: SPRUCE MESSAGE VISIT Date: 2026-02-10 Encounter: Spruce text message followed by video call via Google Meet (2026-02-11); follow-up phone call attempted 2026-02-17 CC: Acute behavioral incident at school with expressed feelings o

Narrative: CHIEF COMPLAINT Annual well-child visit with concerns about back/shoulder pain from swimming, medication management for mental health, and peer therapy evaluation HISTORY OF PRESENT ILLNESS Eamon is a 14-year-old male presenting

Narrative: SPRUCE MESSAGE VISIT Date: 2025-12-01 Encounter: Spruce text message CC: Guanfacine dose clarification and prescription update to reflect current 3mg daily dosing. HPI: Parent contacted Dr. Hobbs to refill guanfacine, noting the

Narrative: ## Outpatient Psychiatric Progress Note **Identifying Information** Patient is a 13-year-old male with a diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD), unspecified type. Parents are present for this telehealth medi

Narrative: SPRUCE MESSAGE VISIT Date: 2025-11-22 Encounter: Video call via Google Meet (2025-11-24) CC: Medication review — discussion about whether to continue sertraline given uncertain efficacy. HPI: Parents requested a check-in specific

Narrative: **SUBJECTIVE:** Chief Complaint: Parental concerns regarding behavioral outbursts and aggression HPI: 13.5-year-old male with ADHD, anxiety, and borderline ASD diagnosis, history of oppositional defiant disorder diagnosed in chil

Narrative: SPRUCE MESSAGE VISIT Date: 2025-10-31 Encounter: Phone call via Spruce (2025-11-11) and video call via Google Meet (2025-11-17) CC: Check-in regarding PEERS social skills program enrollment and ongoing behavioral/mental health ma

Narrative: SPRUCE MESSAGE VISIT Date: 2025-10-24 Encounter: Spruce text message CC: Gastrointestinal discomfort — parent administered Mylanta and sent Eamon back to school. HPI: Dr. Hobbs followed up asking how Eamon was doing, and the pare

Narrative: Subjective • Chief Complaint: Mood concerns, follow-up for depression/anxiety and behavioral regulation. • HPI: Parent reports child “seems a little slowed down” since starting sertraline 75 mg daily. No reported side effects fro

Narrative: SPRUCE MESSAGE VISIT Date: 2025-06-14 Encounter: Spruce text message CC: Sertraline dose increase to 50mg with ongoing monitoring for efficacy and side effects including emotional blunting. HPI: Eamon returned from swim camp and

Narrative: SPRUCE MESSAGE VISIT Date: 2025-06-08 Encounter: Spruce text message CC: Cough and congestion; parent asking about safety of Mucinex with sertraline. HPI: Eamon developed a cough and nasal congestion. Parent asked whether Mucinex

Narrative: SPRUCE MESSAGE VISIT Date: 2025-06-03 Encounter: Spruce text message CC: Possible early side effects of sertraline — manic-like behavior and hot flashes approximately 10 hours after first dose. HPI: Approximately 10 hours after E

Narrative: SPRUCE MESSAGE VISIT Date: 2025-05-30 Encounter: Spruce text message followed by video call (Google Meet, 2025-05-31) CC: Escalating behavioral and social difficulties at school with risk of expulsion, declining grades, social wi

Narrative: SPRUCE MESSAGE VISIT Date: 2025-05-10 Encounter: Spruce text message (with photo of location sent by parent) CC: Back and hip pain ongoing for approximately one year, worsening enough to prompt evaluation. HPI: Eamon reported bac

Narrative: SPRUCE MESSAGE VISIT Date: 2025-02-01 Encounter: Spruce text message followed by in-person office visit (2025-02-23) CC: Annual well-child check for a 13-year-old with concerns about mental health, chronic congestion, and left he

Narrative: SPRUCE MESSAGE VISIT Date: 2025-01-14 Encounter: Spruce text message CC: Resumption of Guanfacine ER with both 1mg and 2mg doses ordered to allow flexible dosing as school year begins. HPI: Following the summer medication break,

Narrative: SPRUCE MESSAGE VISIT Date: 2024-08-22 Encounter: Phone call via Spruce followed by Spruce text messages CC: Severe headache, fever, vomiting, rash, and neck stiffness while on vacation, with concern for meningitis. HPI: Eamon, ap

Narrative: SPRUCE MESSAGE VISIT Date: 2024-05-27 Encounter: Spruce text message CC: Initiation of Guanfacine ER for ADHD/behavioral management with ongoing dose titration and side effect monitoring. HPI: Following the stimulant trial that w

Narrative: SPRUCE MESSAGE VISIT Date: 2024-02-20 Encounter: Spruce text message followed by phone call (2024-03-09) CC: Follow-up on newly started ADHD medication with dose titration and emerging behavioral/emotional side effects. HPI: Eamo